Facebook
Britain's News Portal
Around The Clock
BREAKING
Loading latest headlines…

Brexit Impact on NHS: Staffing and Medicine Costs Worsen, Study Claims

A new study suggests Brexit is exacerbating staffing shortages and increasing medicine costs within the NHS. Researchers highlight a significant decline in EU nurses and pharmacists joining the UK workforce.

  • Study links Brexit to increased NHS staff shortages, particularly among nurses and pharmacists from EU countries.
  • The number of EU nurses joining the NHS fell by 96% between 2016 and 2021.
  • Researchers found a 50% decrease in EU pharmacists joining the UK workforce post-Brexit.
  • Increased medicine costs due to new trade barriers and regulatory divergence cited as a further impact.
  • The Department of Health and Social Care acknowledges workforce challenges but points to recruitment efforts.

A recent study has indicated that the UK's departure from the European Union is contributing to significant challenges within the National Health Service (NHS), specifically through worsening staff shortages and driving up the cost of medicines. The research, published this week, points to a marked decline in the number of healthcare professionals from EU countries choosing to work in the UK since the 2016 referendum and subsequent withdrawal.

According to the findings, the number of nurses from EU nations registering to work in the NHS plummeted by a staggering 96% between 2016 and 2021. Similarly, the study observed a 50% reduction in the number of EU-trained pharmacists joining the UK workforce over the same period. This exodus and reduced inflow of vital medical staff are placing additional strain on an already stretched healthcare system, impacting patient care and waiting times across the country.

Beyond staffing, the study also highlights the financial implications of Brexit on the NHS's procurement of medicines. Researchers suggest that new trade barriers, increased customs checks, and regulatory divergence from EU standards have led to higher import costs for essential drugs. These additional expenses are ultimately borne by the NHS, diverting funds that could otherwise be allocated to patient services or staff remuneration.

The findings underscore a complex interplay of factors affecting the NHS, with Brexit identified as a significant exacerbating force. The report suggests that the UK's new immigration policies, which prioritise skilled workers but introduce more stringent requirements, have made it less attractive for EU healthcare professionals to relocate to the UK. This comes at a time when the NHS is grappling with record waiting lists and a long-term workforce plan to address existing vacancies.

In response to such concerns, the Government, through the Department of Health and Social Care, has often acknowledged the ongoing workforce challenges faced by the NHS. While not directly attributing all issues to Brexit, the department has frequently outlined its efforts to recruit and retain staff, both domestically and internationally. This includes various initiatives aimed at increasing training places for doctors and nurses within the UK and streamlining visa processes for healthcare professionals from non-EU countries.

Why this matters: The study's findings are crucial as they shed light on potential long-term consequences of Brexit for the NHS, directly impacting healthcare provision for millions of UK citizens. It highlights pressures on an already struggling system.

What this means for you: What this means for you: Reduced staff numbers in the NHS could lead to longer waiting times for appointments, operations, and emergency care. Increased medicine costs for the NHS could indirectly affect the range or availability of some treatments.

Related Articles

Get the news that matters.

Join thousands of readers getting the best of British news straight to their inbox.